BeOne Medicines Ltd.
ONCNasdaqCIK 1651308HealthcareFiscal year ends Dec 31
All transactions: 12
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2021-09-10 | Amgen Inc10% owner | Purchase | 165,529 | $302.0615 | $50.0m | Form 4 |
| 2020-12-18 | Amgen Inc10% owner | Grant or award | 25,762 | $260.9465 | $6.7m | Form 4 |
| 2020-12-17 | Amgen Inc10% owner | Grant or award | 74,624 | $260.5396 | $19.4m | Form 4 |
| 2020-12-16 | Amgen Inc10% owner | Grant or award | 85,573 | $248.2612 | $21.2m | Form 4 |
| 2020-12-15 | Amgen Inc10% owner | Grant or award | 67,941 | $239.3065 | $16.3m | Form 4 |
| 2020-08-25 | Amgen Inc10% owner | Grant or award | 59,390 | $248.4859 | $14.8m | Form 4 |
| 2020-08-24 | Amgen Inc10% owner | Grant or award | 59,390 | $239.0959 | $14.2m | Form 4 |
| 2020-08-21 | Amgen Inc10% owner | Grant or award | 64,176 | $230.1797 | $14.8m | Form 4 |
| 2020-08-20 | Amgen Inc10% owner | Grant or award | 64,176 | $234.9941 | $15.1m | Form 4 |
| 2020-08-19 | Amgen Inc10% owner | Grant or award | 64,176 | $234.8768 | $15.1m | Form 4 |
| 2020-08-18 | Amgen Inc10% owner | Grant or award | 40,000 | $230.1797 | $9.2m | Form 4 |
| 2020-07-15 | Amgen Inc10% owner | Grant or award | 29,614,832 | $14.2308 | $421.4m | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 29, 2026, 17:05 ET. Listed shows no prices and gives no investment advice.